Invasive Pneumococcal and Meningococcal Disease

被引:23
|
作者
Fitzgerald, Deirdre [1 ]
Waterer, Grant W. [2 ]
机构
[1] Sir Charles Gairdner Hosp, Dept Resp Med, Verdun St, Nedlands, WA 6009, Australia
[2] Univ Western Australia, Royal Perth Hosp, Wellington St, Perth, WA 6000, Australia
关键词
Pneumococcal; Meningococcal; Invasive; Epidemiology; Treatment; COMMUNITY-ACQUIRED PNEUMONIA; CONJUGATE VACCINE; NEISSERIA-MENINGITIDIS; STREPTOCOCCUS-PNEUMONIAE; UNITED-STATES; CHANGING EPIDEMIOLOGY; RISK-FACTOR; ADULTS; SEROGROUP; CHILDREN;
D O I
10.1016/j.idc.2019.08.007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This review focuses on current knowledge of the epidemiology, prevention, and treatment of invasive pneumococcal (IPD) and meningococcal disease (IMD). IPD decreased significantly with the introduction of effective conjugate vaccines but is on the rise again. Effective antibiotic therapy of IPD includes the combination of a beta-lactam and a macrolide with additional considerations in meningitis. Steroids are mandatory in pneumococcal meningitis but not indicated in pneumococcal pneumonia except in the setting of refractory shock. There is increasing concern about the cardiovascular complications of IPD. IMD continues to be a significant health problem with major concerns about rising antibiotic resistance.
引用
收藏
页码:1125 / +
页数:18
相关论文
共 50 条
  • [1] High mortality of invasive pneumococcal disease compared with meningococcal disease in critically ill children
    Kentigern Thorburn
    Nia Taylor
    Lucia Lopez-Rodriguez
    Michael Ashworth
    Miguel Angel de la Cal
    Hendrik Karel Ferdinand van Saene
    [J]. Intensive Care Medicine, 2005, 31 : 1550 - 1557
  • [2] High mortality of invasive pneumococcal disease compared with meningococcal disease in critically ill children
    Thorburn, K
    Taylor, N
    Lopez-Rodriguez, L
    Ashworth, M
    de la Cal, MA
    Karel, H
    van Saene, F
    [J]. INTENSIVE CARE MEDICINE, 2005, 31 (11) : 1550 - 1557
  • [3] Invasive meningococcal disease - Cerebral perfusion in invasive meningococcal disease
    Flegg, Peter J.
    [J]. BRITISH MEDICAL JOURNAL, 2008, 336 (7659): : 1453 - 1453
  • [4] Invasive meningococcal disease
    Strelow, Vanessa L.
    Vidal, Jose E.
    [J]. ARQUIVOS DE NEURO-PSIQUIATRIA, 2013, 71 (9B) : 653 - 658
  • [5] Invasive pneumococcal and meningococcal disease: association with influenza virus and respiratory syncytial virus activity?
    Jansen, A. G. S. C.
    Sanders, E. A. M.
    Van Der Ende, A.
    Van Loon, A. M.
    Hoes, A. W.
    Hak, E.
    [J]. EPIDEMIOLOGY AND INFECTION, 2008, 136 (11): : 1448 - 1454
  • [6] Invasive meningococcal and pneumococcal disease in Switzerland: cost-utility analysis of different vaccine strategies
    Ruedin, HJ
    Ess, S
    Zimmermann, HP
    Szucs, T
    [J]. VACCINE, 2003, 21 (27-30) : 4145 - 4152
  • [7] Invasive pneumococcal disease
    Randle, Elise
    Ninis, Nelly
    Inwald, David
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION, 2011, 96 (05): : 183 - 190
  • [8] Invasive Meningococcal Disease in Childhood
    Brayer, Anne F.
    Humiston, Sharon G.
    [J]. PEDIATRICS IN REVIEW, 2011, 32 (04) : 152 - 160
  • [9] Epidemiology of invasive pneumococcal and meningococcal disease in southeastern Ontario? Is universal infant immunization cost-effective?
    Simpson, CDA
    Onyett, H
    [J]. PEDIATRIC RESEARCH, 2003, 53 (04) : 307A - 307A
  • [10] Genetic variation of innate immune response genes in invasive pneumococcal and meningococcal disease applied to the pathogenesis of meningitis
    M S Sanders
    G T J van Well
    S Ouburg
    S A Morré
    A M van Furth
    [J]. Genes & Immunity, 2011, 12 : 321 - 334